Qtrly's are designed to be retrospective, very rarely will a company have additional news beyond what has been announced to disclose.
On that note, this is new - In September 2019, the Company signed a six-week licence agreement for ilumenTM with a British multinational mining company. The license agreement allows for one of the company’s division consisting of approximately 500 employeesin Singapore (Singapore), United Kingdom (London), Australia (Brisbane), Chile (Santiago), Brazil (Rio De Janeiro), and South Africa (Johannesburg) to take part in the ilumenTM wellbeing program that commenced in October 2019. This agreement marked another step forward for Medibio in achieving its global commercialisation strategy of ilumenTM.
MEB Price at posting:
1.1¢ Sentiment: Buy Disclosure: Held
